Turbine raises €22.5M Series B round
24 February 2026· Budapest, Hungary· health, oncology, ai, biotech, b2b, pure_software
The funding will be used to expand Turbine's AI-powered virtual cell platform into immunology and skin research, moving beyond its initial focus on oncology and transforming drug discovery into a predictable engineering discipline.
Investors
LeadInteractive Venture Partners
Also participating
AccelBeiersdorf Venture CapitalMercia Asset ManagementMSD Global Health Innovation
About Turbine
Headquarters
Budapest, Hungary
Founded
2015
Team Size
51–200
Sectors
healthoncologyaibiotechb2bpure_software